Find Research Projects

Search results

• Intelligent Risk Assessment for Financial Services

  Beheshti, A., Wu, J., Alinejad Rokny, H., Zhang, X., Jolfaei, A. & Wood, S.

  25/06/21 → 1/07/25

  Project: Research

• ACT16146: Randomized, open-label, phase 2 study of SAR408701 combined with pembrolizumab and pembrolizumab alone in patients with CEACAM5 and PD-L1 positive advanced/metastatic non-squamous non–small-cell lung cancer (NSQ NSCLC)

  Park, J. & Chapman, N.

  14/08/20 → 1/07/25

  Project: Research

• EV-302: An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab with or without chemotherapy, versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer

  Zhang, A., Gurney, H. & Chapman, N.

  5/11/20 → 16/07/25

  Project: Research

• A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, 60-Week, Phase II Clinical Trial of Three Re-Purposed Medications in Moderate Severity Parkinson’s Disease

  Rowe, D. & Gan, R.

  10/09/20 → 29/07/25

  Project: Research

• YH002002: A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of YH002 in Subjects with Advanced Solid Malignancies

  Park, J. & Chapman, N.

  18/09/20 → 30/07/25

  Project: Research

• Physical musicality: Optimising lived experience among older adults

  Thompson, B., Davidson, J., Liu-Ambrose, T., Ho, R. T. H. & Green, R.

  1/08/21 → 31/07/25

  Project: Research

• MRFF: Cost-Utility Comparison of Down-Titration Strategies for Safer and More Efficient Use of Biologics in Adults with Rheumatoid Arthritis and Psoriatic Arthritis

  March, L., Buchbinder, R., Lassere, M., Proudman, S. M., Thomas, R., Schofield, D., Xue, M., Wechalekar, M. D., Whittle, S. L., Sinnathurai, P., Keen, H. I., Hill, C., Youssef, P., Benham, H., Bereza-Malcolm, L., Willers, C., Schachna, L., Muller, S., Perera, C. & Tymms, K.

  1/08/21 → 31/07/25

  Project: Research

• ADG116-1003: A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors

  Park, J., Chapman, N. & Sabanathan, D.

  14/09/20 → 27/08/25

  Project: Research

• SBT6050-1001: A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2

  Sabanathan, D., Park, J. & Chapman, N.

  2/09/20 → 27/08/25

  Project: Research

• Sydney Quantum Academy Scholarship_Volz/Mahajan

  Volz, T.

  1/09/21 → 31/08/25

  Project: Research

• Bayer 20510: A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of novel anti-hormonal therapy (NAH) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of NAH

  Gurney, H. & Chapman, N.

  1/12/20 → 10/09/25

  Project: Research

• CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors

  Park, J., Sabanathan, D. & Chapman, N.

  30/10/20 → 24/09/25

  Project: Research

• EFC15935: A randomized, multicentre, double-blind phase 3 study of SAR439859 plus palbociclib versus letrozole plus palbociclib for the treatment of patients with ER (+), HER2 (-) breast cancer who have not received prior systemic anti-cancer treatment for advanced disease

  Sabanathan, D., Park, J. & Chapman, N.

  30/09/20 → 30/09/25

  Project: Research

• Next generation adjuvants for advanced immunotherapies

  Garcia-Bennett, A.

  3/01/20 → 3/10/25

  Project: Research

• AMPLITUDE: A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

  Gurney, H. & Chapman, N.

  30/11/20 → 15/10/25

  Project: Research

• MK6842-013: Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma

  Gurney, H., Zhang, A. & Chapman, N.

  13/11/20 → 15/10/25

  Project: Research

• ENZA-P: ANZUP 1901: A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide

  Zhang, A. & Chapman, N.

  26/10/21 → 22/10/25

  Project: Research

• WO42133/TRIO038: TRIO038: A randomized, multicenter, open-label, two-arm, phase II neoadjuvant study evaluating the activity, efficacy, safety and pharmacokinetics of GDC-9545 in combination with palbociclib compared with anastrozole with palbociclib for postmenopausal women with operable estrogen receptor positive (ER+) and HER-2 negative (HER-2-) untreated breast cancer.

  Sabanathan, D. & Chapman, N.

  18/12/20 → 26/11/25

  Project: Research

• Art & Wonder: Young Children and Contemporary Art. A collaboration between the Museum of Contemporary Art Australia and Macquarie University

  Britt, C., Palmer, A., Shepherd, W., Robertson, J., Davis, B. & Lavina, L.

  1/09/17 → 1/12/25

  Project: Research

• Keynote B61: MK3475-B61 - A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants with First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61)

  Gurney, H., Chapman, N. & Tan, P.

  1/02/21 → 10/12/25

  Project: Research

• A Multi-Centre Randomised Controlled Trial of Polysomnographic Titration of Non-Invasive Ventilation in Motor Neurone Disease

  Berlowitz, D. J., Rowe, D., Howard, M., Piper, A., Graco, M., Braat, S., Singh , B., Sousa , T. V., Lannin , N., Gan, R., Ordonez Artunduaga, P., Pan, J., Barnes, K., Aiyappan, V., Curtin , D., Wu, P. & Birks, C.

  1/02/21 → 31/12/25

  Project: Research

• Therapeutic drug actions in the nervous system

  Connor, M.

  13/12/20 → 31/12/25

  Project: Research

• FoxG1 Syndrome PhD Scholarship

  Delerue, F.

  29/06/21 → 31/12/25

  Project: Research

• Coordinating Committee, International Lithosphere Program 'Lithosphere of East Antarctica'

  Reading, A., Selway, K. & King, M.

  1/01/21 → 31/12/25

  Project: Research

• WIO-R2R: WIO-Ridge to Reef: An Ecosystem Based Approach to Biodiversity Conservation in the Western Indian Ocean

  Mbui, M.

  1/01/16 → 31/12/25

  Project: Research

• IN210100008: Building An Indigenist Health Humanities Collective

  Bond, C., Whop, L., Brough, M., Mukandi, B., Macoun, A., Newhouse, G., Drummond, A., McQuire, A., Stajic, J. & Kajlich, H.

  26/02/21 → 31/12/25

  Project: Research

• Michael Morgan HDR Scholarship in brain AVM research

  Stoodley, M. & McRobb, L.

  1/06/21 → 31/12/25

  Project: Research

• Macquarie University Centre for Reading

  Castles, A.

  21/06/21 → 31/12/25

  Project: Research

• Screening and Risk Reduction for Dementia in Primary Care

  Wuthrich, V.

  1/01/21 → 31/12/25

  Project: Research

• Who am I? Disrupted self-identity development in early adulthood and intrusive thoughts and behaviours

  Wong, S. F. & Rapee, R.

  1/01/22 → 31/12/25

  Project: Research

• Novel nanotechnology strategies for drug delivery to the brain and preclinical evaluation of therapies

  Shi, B.

  1/01/21 → 31/12/25

  Project: Research

• USYD Led: Reducing the Morbidity of Head and Neck Cancer Treatment

  Clark, J., Gupta, R., Lee, J., Ashford, B. G., Ranson, M., Boyer, M., Rizos, H., Yang, J. Y. H., Suaning, G. J. & Wallace, G. G.

  1/02/21 → 31/01/26

  Project: Research

• Investigator Grant: Creating an Empirically Based Classification System for Mental Illness

  Forbes, M.

  1/03/21 → 28/02/26

  Project: Research

• CAPTIVATE: Randomized, Open label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration resistant Prostate Cancer (CAPTIVATE)

  Gurney, H., Zhang, A., Chapman, N. & Tan, P.

  1/11/21 → 2/03/26

  Project: Research

• TAR-200: Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin (BCG) who are Ineligible for or Elected Not to Undergo Radical Cystectomy

  Patel, M., Chapman, N. & Tan, P.

  13/08/21 → 15/04/26

  Project: Research

• ACT16849: A Phase 2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR-707) combined with other anticancer therapies for the treatment of participants with lung cancer or pleural mesothelioma

  Park, J., Chapman, N. & Tan, P.

  13/05/21 → 15/04/26

  Project: Research

• CONTACT-02: A phase 3 randomized, open label, controlled study of cabozantinib (XL184) in combination with Atezolizumab vs second novel hormonal therapy in subjects with high-risk, metastatic castration-resistant prostate cancer

  Gurney, H., Zhang, A. & Chapman, N.

  3/09/21 → 29/04/26

  Project: Research

• Keynote-B49: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer

  Sabanathan, D. & Chapman, N.

  20/06/21 → 27/05/26

  Project: Research

• SHR3162-III-305: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Placebo Combined with AA-P as First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

  Gurney, H., Chapman, N. & Zhang, A.

  1/09/21 → 27/05/26

  Project: Research

• Cultivate: A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease

  Leong, R. & Chapman, N.

  16/08/21 → 1/06/26

  Project: Research

• SAMETA: A Phase III, Open Label, Randomised, Controlled, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Savolitinib plus Durvalumab versus Durvalumab in Participants with MET-Driven, Unresectable and Locally Advanced, or Metastatic Papillary Renal Cell Carcinoma (PRCC)

  Gurney, H., Zhang, A. & Chapman, N.

  6/09/21 → 4/06/26

  Project: Research

• FT210100241: Seeking 'Closure' in Unsolved Homicide Cases

  Rossmanith, K.

  27/06/22 → 26/06/26

  Project: Research

• Cooperative Research Centre for Smart Satellite Technologies and Analytics (SmartSat CRC)

  Reisenfeld, S., Cetin, E., Abbas, R., Kong, Y., Vesilo, R., Esselle, K. & Hashmi, R.

  8/01/20 → 30/06/26

  Project: Other

• LeapForward: Evaluating a multimodal psychosocial approach to workplace injury management

  Jones, T. & Dean, C.

  1/07/21 → 30/06/26

  Project: Research

• GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma

  Park, J., Sabanathan, D., Xia, C., Kim, S. & Chapman, N.

  3/08/21 → 29/07/26

  Project: Research

• OXTOX: Can Oxaliplatin dose reduction and neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer – a phase II randomised study

  Moth, E., Poursoltan, P. & Chapman, N.

  2/11/21 → 1/10/26

  Project: Research

• TACTI-003: TACTI-003 (Two ACTive Immunotherapeutics): A multicenter, open label, randomized, Phase II trial to investigate a soluble LAG-3 fusion protein, eftilagimod alpha (efti; IMP321) in combination with pembrolizumab (PD-1 antagonist) for first line treatment of subjects with unresectable recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC)

  Park, J. & Chapman, N.

  1/11/21 → 1/10/26

  Project: Research

• WO41554: A PHASE III, Randomized, Double-Blind, Placebo-Controlled study evaluating the efficacy and safety of GDC-0077 Plus Palbociclib and Fulvestrant Vs Placebo Plus Palbociclib and Fulvestrant in Patients with PIK3CA-mutant, Hormone Resceptor Positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.

  Sabanathan, D. & Chapman, N.

  15/12/21 → 13/10/26

  Project: Research

• Harmonic analysis: singular integrals, function spaces and related topics

  Duong, X.

  31/10/21 → 30/10/26

  Project: Research

• Faith in Development: Religion, Gender and Resource Extraction in PNG

  Hermkens, A.

  19/11/21 → 18/11/26

  Project: Research